trial · primary record
LY4337713
Ovarian Neoplasms
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 340 |
| Primary completion | 2033-03 |
| Primary endpoint | Phase 1a: Percentage of Participants with Dose Limited Toxicity (DLT) Toxicities |
| Registry ID | NCT07213791 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:07.793Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07213791
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.